CEACAM5 and colorectal carcinoma: Although carcinoembryonic antigen (CEA) and other tumor markers have been widely used in CRC diagnosis and prognosis evaluation clinically, more efficient biomarkers are still needed to be identified for early diagnosis of CRC, and the study of therapeutic targets may be the main direction for further improvement of patient survival 1.